SIRT1 and type 2 diabetes mellitus: According to a study, formononetin may improve neuropathic symptoms in type 2 diabetic rats by boosting the expression of SIRT1 (Sirtuin 1) and NGF in diabetic animals (Oza and Kulkarni 2020).